In the BioHarmony Drug Report Database

"Preview" Icon

Beractant

Survanta (beractant) is an unknown pharmaceutical. Beractant was first approved as Survanta on 1991-07-01. It is used to treat newborn respiratory distress syndrome in the USA.

 

Trade Name

 

Survanta
 

Common Name

 

beractant
 

ChEMBL ID

 

CHEMBL1201624
 

Indication

 

newborn respiratory distress syndrome
 

Drug Class

 

Pulmonary surfactants; tachykinin (neurokinin) receptor antagonists

Image (chem structure or protein)

Beractant structure rendering